Activist Starboard ends BMS proxy war after advisories back Celgene deal
admin 1st April 2019 Uncategorised 0Starboard Value has officially given up on trying to scuttle the mammoth Bristol-Myers Squibb-Celgene merger. Apparently, positive word from influential proxy advisory firms was enough to put the nail in the coffin on the activist’s campaign. More: Activist Starboard ends
read more